Document is current
Any future updates will be listed below
-
Authors
Han, Jie
Gao, Yuanjing
Huo, Ling
Wang, Dong
Xie, Xiaozheng
Zhang, Rui
Xiao, Mengsu
Zhang, Nan
Lei, Meng
Wu, Quanlin
Ma, Lu
Sun, Chao
Wang, Xinyi
Liu, Lei
Cheng, Shuzhen
Tang, Binghui https://orcid.org/0000-0003-3317-4966
Wang, Liwei https://orcid.org/0000-0003-1739-2621
Zhu, Qingli https://orcid.org/0000-0001-9556-9192
Wang, Yong https://orcid.org/0000-0001-7682-0433
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (No. 82171967)
National High-level Hospital Clinical Research Funding (No. 2022-PUMCH-B-065, No. 2022-PUMCH-B-066)
Capital’s Funds for Health Improvement and Research (No. 2024-2-40210)
Beijing Hope Run Special Fund of Cancer Foundation of China (No. ZZ2024A10)
China Postdoctoral Science Foundation (No. 2017M620683)
Dongcheng District Excellent Talent Training Subsidy Program
- License Information
-
More Information
Article History
Received: 4 August 2024
Accepted: 3 June 2025
First Online: 16 June 2025
Declarations
:
: This multicenter study was divided into two parts: model development using a retrospective dataset and model validation using a prospective dataset. The retrospective study was approved by Ethics Committee of National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College (No. 22/386-3588) with a waiver granted for the requirement of informed consent. The prospective study was approved by Ethics Committee of National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College (No. 21/328-2999), and informed consent was obtained from each patient or their guardian before the US examination.
: Not applicable.
: The authors declare no competing interests.
